precision medicine

Research in Review

Understanding the Role of Prolactin Receptor in Triple Negative Breast Cancer

10/28/2016

JCP Editors

Screening breast cancer patients for the prolactin receptor could improve the prognosis for patients and help avoid unnecessary and invasive treatments, according to new research that examined the prognostic and...

...

10/28/2016

Journal of Clinical Pathways

Potential Biomarkers for Bladder Cancer Identified

10/27/2016

JCP Editors

Tumor cells collected during the removal of a cancerous bladder may help clinicians better identify high-risk cancers, determine prognosis, refine their use of biomarkers, and provide more personalized care,...

Tumor...

10/27/2016

Journal of Clinical Pathways

Research in Review

Recurrence Score Assay Helping to Guide Breast Cancer Decision Making

10/26/2016

JCP Editors

Use of the 21-gene recurrence score (RS) assay is helping clinicians and patients decide which treatments are best for them, according to a large-scale survey of more than 3000 women treated for breast...

Use of...

10/26/2016

Journal of Clinical Pathways

Research in Review

Androgen Therapy May Improve Survival in Elderly Patients With Leukemia

10/24/2016

JCP Editors

Maintenance therapy with norethandrolone may improve survival in elderly patients with acute myeloid leukemia (AML) without increasing toxicity, according to a study published in the Journal of Clinical Oncology....

...

10/24/2016

Journal of Clinical Pathways

Research in Review

N-Acetyle Cysteine Improves Immunotherapy for Melanoma

10/18/2016

JCP Editors

Culturing T cells in N-acetyle cysteine (NAC) before they are infused as immunotherapy may improve effectiveness and outcomes in patients with melanoma, according to findings reported in Cancer Research....

...

10/18/2016

Journal of Clinical Pathways

Research in Review

CML Mutations Associated With Treatment Failure

10/18/2016

JCP Editors

Somatic mutations may predict treatment failure with tyrosine kinase inhibitors (TKIs) in patients with chronic myeloid leukemia (CML), according to a study published in Blood, the journal of the American Society of...

...

10/18/2016

Journal of Clinical Pathways

Research in Review

Nivolumab Superior to Standard Therapy for Recurrent Head and Neck Cancer

10/14/2016

JCP Editors

Patients with recurrent or metastatic squamous-cell carcinoma of the head and neck may benefit more from treatment with nivolumab than standard, single agent therapy, according to results from a trial published in...

...

10/14/2016

Journal of Clinical Pathways

Quiz

Friday Morning Quiz: Week of October 9-15

10/13/2016

JCP Editors

Which of the following drugs added to adjuvant endocrine therapy helped to reduce the risk for contralateral breast cancer in women with invasive breast...

Which...

10/13/2016

Journal of Clinical Pathways

Research in Review

Tamoxifen May Reduce Contralateral Breast Cancer Risk

10/11/2016

JCP Editors

Adjuvant endocrine therapy with tamoxifen or aromatase inhibitors may reduce the risk for contralateral breast cancer (CBC) in women with invasive breast cancer according to results from a study published in JAMA...

...

10/11/2016

Journal of Clinical Pathways

Research in Review

Blinatumomab Induces Complete Remission in Children with BCP-ALL

10/07/2016

JCP Editors

Results from a phase I/II single-arm trial suggest that blinatumomab may have an antileukemic effect in children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia (BCP-ALL). ALL is a progressive...

...

10/07/2016

Journal of Clinical Pathways